GlobeNewsWire
07 Jun 2026, 23:41 UTC · 2d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
GNI Group is acquiring 100% of Ayumi Pharmaceutical Holdings for approximately ¥44.8 billion. — A significant acquisition of a market leader suggests aggressive expansion and immediate scale-up of assets.
+0.60GNI Group expects combined fiscal 2026 revenue to reach approximately ¥65.2 billion following the transaction. — Provides a concrete, positive quantitative target for growth that analysts can model.
+0.50GNI Group gains control of Calonal, which holds over 80% of Japan's domestic acetaminophen market. — Acquiring a dominant market share in a core drug provides stable, high-moat cash flows.
+0.40Ayumi Pharmaceutical reported ¥38.5 billion in revenue and ¥6.2 billion in operating profit for the fiscal year ended March 2026. — Confirms the target is profitable, reducing the risk profile of the acquisition.
Continue reading
6 related stories
Top 2 movers · tap to explore
Which stocks this story touches
The company is acquiring Ayumi Pharmaceutical, which is expected to substantially increase its scale, revenue, and commercial presence in Japan.
As a subsidiary of GNI Group, it benefits from the parent company's expanded scale and strategic growth in the biopharmaceutical sector.
Blackstone is exiting its investment in Ayumi Pharmaceutical through a sale to GNI Group.
Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card. Covers all 10 tickers this story moves.
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
GlobeNewsWire
1h ago
